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Objectives: Immune age-related abnormalities may synergise with osteoarthritis (OA) pathology. We
explored whether abnormalities in the blood immune cell composition are present in OA, beyond defects
typically associated with ageing.
Design: Blood was collected from 121 healthy controls (HC) and 114 OA patients. Synovial biopsies were
obtained from another 52 OA patients. Flow cytometry was used to establish the frequencies of lineage
subsets, naïve, memory and regulatory T and B-cells, cells with an abnormal phenotype related to
inﬂammation (IRC) and memory-like CD8þ T-cells. Multivariate analysis of covariance (MANCOVA) was
used to determine whether the relative subset frequencies differed between HC and OA, controlling for
age.
Results: Expected histology and T/B-cell inﬁltration were observed.
Following age adjusted analysis, we conﬁrmed the lack of age association in HC for CD4þ, B, NK and NKT
cells but a negative trend for CD8þ T-cells. In OA, CD4þ T-cell and B-cell frequency were lower compared
to HC while CD8þ T-cell frequencies were higher. CD8þmemory-like cells were more likely to be found in
OA (odds ratio ¼ 15). Increased CD8þ IRC frequencies were also present in OA. The relationship between
age and CD4þ or CD8þ naïve T-cells in HC were changed in OA while the age relationships with memory
cells were lost. The increase in CD4þ Treg with age was also lost in OA. B-cells showed limited evidence of
disturbance.
Conclusions: Immune dysfunction may be present in OA beyond what appears related to ageing; this
requires further investigation.
© 2015 The Authors. Published by Elsevier Ltd and Osteoarthritis Research Society International. This is
an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).Introduction
Ageing is a complex phenomenon involving several human
systems, simultaneously interacting at different levels1. It affects
cells, tissues and whole organs; it diminishes homeostasis and
increases vulnerability2. Many pathways, including the immuneF. Ponchel, Leeds Institute of
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r Ltd and Osteoarthritis Research Ssystem (IS), have been shown to be involved in ageing and age-
related diseases3,4. In the very elderly, infectious disease is the
primary cause of death, highlighting the importance of the
adaptive IS. Acquired immune responses decline with age, with
poor responses to vaccination, increased susceptibility to infec-
tion, higher prevalence of certain cancers associated with viral
infection or emerging pathogens5,6. In addition, there is increased
intrinsic difﬁculty in dealing with common pathogens, notably
herpes zoster or cytomegalovirus (CMV). Paradoxically, this
decline is accompanied by an increase in auto-reactivity and the
generation of autoantibodies7,8. In addition, a wide range of
etiological factors contribute to increased low-grade inﬂamma-
tion (known as inﬂammageing) including chronic antigenic
burden, decreased production of sex steroids, subclinical disor-
ders such as atherosclerosis, asymptomatic bacteriuria, as well as
cellular senescence of immune cells3,4,6. The inﬂammatoryociety International. This is an open access article under the CC BY license (http://
Table I
Descriptive characteristics of the studied groups
HC (n ¼ 121)
Mean age in years(SD), range 44.0 (12.7), 19-71
Sex M/F 37/85
OA biopsies (n ¼ 52)
Mean age in years(SD), range 57 (13.5), 30-89
Sex M/F 32/82
OA (n ¼ 114)
Mean age in years(SD), range 64 (10.9), 48-85
Sex M/F 32/82
Mean BMI, (range)* 30 (21e50)
Mean symptom duration in years, (range)* 10 (1e35)
Family history (n)* 46
Anatomical localisation (n)y
knee 76
hip 30
hand 32
foot 13
ankle 2
* BMI was available for 96 OA patients, while symptom duration and family
history were recorded for 62 patients.
y Some patients had OA in more than one joint area.
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contributor to age-related conditions.
Osteoarthritis (OA) is strongly age-related9, with evidence of
radiographic OA highly prevalent in individuals over the age of
60, though clinically symptomatic OA occurs in a smaller per-
centage10. Many of the age-related and inﬂammation-prone
pathways may be involved in OA. Certain abnormalities of the
IS including change in T-cell reactivity11, development of auto-
antibodies12, telomere shortening13 and activation of inﬂamma-
tory mechanisms14 have been reported in OA15. Biomechanical
stresses have been proposed as a source of immune stimulation
in OA16,17 and another hypothesis proposes that collagen break-
down reveals neo-antigens leading to T/B-cell responses18.
Products of cartilage/bone degradation promote persistent low
grade inﬂammation and synovitis both increasingly recognised
as important symptoms of OA19. Innate immune responses to
calcium crystal deposition have also been reported to activate the
inﬂammasome pathway20.
We hypothesized that the complex interplay between the
musculoskeletal system and IS may be in part responsible for the
development of the clinical syndrome of OA. The aims of this study
were therefore to determine if abnormalities in the blood immune
cell composition were associated with OA, beyond the defects
related to age. We investigated lineage composition for CD4þ and
CD8þ T-cells, B-cells, NK-cells and CD56þ T-cells (subsequently
referred to as NKT-cells) and phenotyped T-cells and B-cells further
for naïve, memory and regulatory subsets as well as for two other
cell populations: IRC and memory-like cells.Materials and methods
Patients
Blood samples (EDTA 4 ml) were collected from 121 healthy
controls (HC) and 114 patients with OA, and arthroscopically-
obtained synovial tissue biopsies from a separate 52 OA patients.
The studies were approved by the local Research Ethics Committee
and all participants gave written an informed consent.
The HC were recruited from Leeds University staff to speciﬁcally
include awide range of age in order to establish reference ranges for
healthy ageing. Particular attentionwas given to excluding HC with
any joint symptoms.
The OA blood samples were collected from patients recruited
from two main sources. Firstly patients from primary and second-
ary care clinics were recruited into clinical studies where ACR OA
clinical criteria were required for inclusion (n ¼ 74); a baseline
blood specimen was obtained in these participants. Secondly pa-
tients in a secondary care orthopaedic clinic who had been referred
for joint replacement and had radiographic OA were sampled
(n¼ 40). The included patients had OA at different anatomical sites,
with themajority having knee OA but over half having OA in at least
two anatomical locations (Table I provides detailed numbers). De-
mographic and clinical characteristics were recorded in the OA
patients: age, sex, height and weight, calculated BMI and anatom-
ical location of joint(s) affected by OA (summarised in Table I).
Synovial tissue samples were obtained from patients with ACR
clinical OA and evidence of cartilage loss during knee arthroscopy,
using 3.5 mm grasping biopsy forceps under direct vision using a
Hopkins 2.7 mm 300 arthroscope. A Visual Analogue Score (VAS)
was used as a parameter of macroscopic joint inﬂammation.
Scoring was based on the visual inspection of vessels and hyper-
emia in the synovial membrane21. Synovial biopsies were taken
from areas of macroscopic synovitis. Age and sex were recorded for
these patients (Table I).Tissue sample processing
Tissue for light microscopy was ﬁxed in 10% neutral buffered
formalin. Sections were then dewaxed in xylene and ethanol, then
washed in water and stained with Mayers Haematoxylin and
counterstained in 1% aqueous Eosin Y after which they were
dehydrated in ethanol cleared in xylene and mounted in DPX.
The parafﬁn embedded sections were dewaxed in Access Super
solution (Menarini diagnostics) then stained. Staining was per-
formed using standard X-Cell plus staining kit (Menarini di-
agnostics) with modiﬁcation according to individual primary
antibody host species according to manufacturer's instructions.
Incubation were with primary monoclonal antibody anti CD3
(rabbit monoclonal clone SP7 Abcam cat ab16669 (1:200), anti
CD68 (Rat monoclonal Abcam ab53444, 1:100) and anti CD20 (M-
20 Goat polyclonal Santa Cruz sc-7735, 1:200)). The slides were
then counterstained in haematoxylin.Flow cytometry
8-colours ﬂow-cytometry was performed using standard pro-
tocols for cell surface and intracellular staining to establish the
frequencies of: CD4þ and CD8þ T-cells (CD3þCD4þ and CD3þCD8þ),
B-cells (CD19þ), NK (CD56þCD3-) and NKT-cells (CD56þCD3þ).
CD4þ and CD8þ T-cells with a naïve (CD45RBhighCD45RAþCD62Lþ)
and memory (CD45RBlowhCD45RACD62L) phenotypes were
subsequently analysed as well as cells with an abnormal phenotype
(Inﬂammation Related Cells, IRC: CD45RBhigh CD45RAþCD62L)
identiﬁed in inﬂammatory arthritis in relationship with CRP22. An
additional CD8þ T-cell population with a memory-like phenotype
(CD45RBlowCD45RACD62Lþ) was also present in some but not all
samples (see Supplementary Figures). Regulatory T-cells
(CD3þCD4þ CD25high Foxp3þCD127low) were identiﬁed in a sepa-
rate panel. B-cell analysis included a phenotyping panel for naïve
(CD19þCD27CD38high), memory (CD19þCD27þCD38low), and pu-
tative regulatory-B-cells deﬁned as transitional T2 cells
(CD19þCD38highCD24high), which are known to include regulatory
B-cells in human even if not only those, the intracellular expression
of IL-10 remaining the deﬁning feature of Breg. A population of Pre-
plasma cells (PPC: CD19þCD27þCD38high) could be identiﬁed in
some sample but not all. All antibody clones used are described in
Supplementary ﬁle Table S1 with gating strategies exempliﬁed in
Figure S1 (A, B, C, D).
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Comparison between tissue architecture groups in synovial bi-
opsies was performed using ManneWhitney U-test and Spear-
man's correlation coefﬁcient.
Following appropriate transformation of variables where
necessary to an approximate Gaussian distribution, we used
multivariate analysis of covariance (MANCOVA) to determine
whether the relative subset frequencies differed between HC and
OA, controlling for age. This approach was chosen to account for the
inter-relationships between frequencies therefore we ran separate
models for lymphocyte lineages (including NK, NKT, CD8þ T-cells,
CD4þ T-cells, B-cells), CD4þ T-cell phenotypes (naïve, memory and
IRC), CD8þ T-cell phenotypes (as for CD4þ) and B-cells (naïve,
memory and putative T2/Breg). Age-adjusted between-groups
differences were ﬁrst calculated assuming the association with
age was the same in both groups. An interaction term between age
and group was then added to verify whether this assumption was
reasonable. If the interaction was signiﬁcant at the 10% level,
changes with age were presented separately for HC and OA.
In the case of Treg cells, linear regressionwas used, according to
the same analysis strategy. Memory-like CD8þ T-cells and PPC were
analysed separately as not detected in all samples, ﬁrst using lo-
gistic regression to identify age-adjusted between-group differ-
ences in the odds of them being present, followed by linear
regression restricted to patients in whom the cells were detected.
Analyses were conducted in SPSS 21.0.0.1 and Stata 13.1.
Results
Synovial tissue
In 26 of the OA synovial tissue biopsies, a VAS was available and
ranged from 3 to 80 with a median at 35, suggesting quite high
inﬂammatory scores. Synovitis was evaluated using a scoring sys-
tem21,23 utilising thickness of the lining layer, inﬁltration ofFig. 1. Lineage cell detection in OA synovial tissue. IHC for T-cells (CD3) B-cells (CD20) and
centre like structure tissue architecture.immune cells in the stromal compartment of the synovial mem-
brane and their higher organisation in aggregates or germinal
centre-like structures. The score ranged from 0 to 8 with a median
of 2.5. VAS was directly associated with the synovitis score
(rho ¼ þ0.493, P ¼ 0.012).
In 13 samples, the histological appearance of the tissue was
normal (synovitis score of 0). In half of the samples (28/52), T-cells
(CD3) and B-cells (CD20) could be identiﬁed, suggesting diffuse
inﬁltration and this was associated with intermediate VAS (9e70)
and synovitis histological scores (0.5e5). In 10 cases formation of
small lymphocyte aggregates could be observed (Fig. 1), VAS range
6e80, and synovitis scores 2.5e6. The presence of an ectopic
germinal centre-like structure was only seen in one sample (VAS
72, synovitis score 8).
Differences in immune cell composition between HC and OA
Lymphocyte lineages
When all immune cell lineages were considered simultaneously,
there was an overall association with age (P ¼ 0.008) but having
adjusted for age there was no evidence of a difference between HC
and OA (F(4,195) ¼ 1.14, P ¼ 0.338). Assuming the association with
age was the same in both groups, looking at the age-adjusted re-
sults for individual lineages (Table II), there were no differences in
the levels of each lineage between HC and OA, consistent with the
non-signiﬁcant overall test. However, when an interaction term
was added to the multivariate model, the association with age
differed between OA and HC (P ¼ 0.001; Fig. 2). This interaction
remained statistically signiﬁcant (P ¼ 0.010) when the analysis was
restricted to individuals aged 48 or above (the minimum age in the
OA group).
Looking at individual lineages (Fig. 2), there was no association
with age in HC for NK and NKT-cells, whilst their frequencies were
higher in OA patients with increasing age. For CD4þ T-cells and B-
cells there was no association in HC, but frequencies were lower in
OA patients. For CD8þ T-cells the trendswere in opposite directions,macrophage (CD68) in three typical OA biopsies with diffuse, aggregates or germinal
Table II
Differences in immune cell relative frequencies between HC and OA patients obtained from multivariate analyses
Age-adjusted results assuming association with age is the
same in HC and OA
Allowing age association to differ between
HC and OA
HC OA Difference between groups Association with age HC OA Interac-
tion
Mean (95% CI) P value Change per
year (95% CI)
P value Change per
year (95% CI)
Change per
year (95% CI)
P value
Lymphocyte lineage
Age mean, SD (range)
n ¼ 93
44.8, 12.1
(19e69)
n ¼ 108
64.2,8.9
(48e85)
NK, mean % 14.92 12.97 1.95 (4.70, 0.79) 0.162 0.12 (0.03, 0.22) 0.011 0.01 (0.11, 0.13) 0.31 (0.16, 0.46) 0.003
NKT, mean % 4.47 4.49 0.02 (1.88, 1.91) 0.987 0.09 (0.02, 0.15) 0.010 0.07 (0.02, 0.15) 0.12 (0.02, 0.23) 0.025
CD8, mean % 21.16 19.62 1.54 (4.78, 1.69) 0.348 0.03 (0.14, 0.09) 0.632 0.12 (0.26, 0.03) 0.11 (0.07, 0.29) 0.051
CD4, mean % 49.29 51.53 2.24 (1.76, 6.24) 0.271 0.12 (0.26, 0.02) 0.087 0.06 (0.12, 0.23) 0.41 (0.63, 0.19) 0.001
B-cells, mean % 10.16 11.40 1.23 (0.45, 2.92) 0.149 0.06 (0.12, 0.00) 0.038 0.02 (0.09, 0.06) 0.13 (0.23, 0.04) 0.066
CD4 T-cells
Age mean, SD (range)
n ¼ 81
43.1, 13.4
(19e69)
n ¼ 101
63.8, 8.9
(48e83)
Naïve, mean % 36.44 38.19 1.75 (2.74, 6.25) 0.443 0.35 (0.50, 0.21) <0.001 0.50 (0.68, 0.32) 0.09 (0.33, 0.16) 0.008
Memory, mean % 17.98* 16.79* 0.93 (0.78, 1.11)y 0.444 0.97 (0.39, 1.55)z 0.001 1.40 (0.68, 2.12)z 0.24 (1.80, 1.34)z 0.048
IRC, mean % 1.19* 1.27* 1.07 (0.73, 1.57)y 0.723 0.41 (0.85, 1.70)z 0.520 N/A N/A 0.167
Regulatory T-cells
Age mean, SD (range)
n ¼ 104
41.8, 12.7
(19e69)
n ¼ 114
63.9, 9.0
(48e83)
Treg, mean % 4.84 3.37 1.17 (1.72, 0.63) <0.001 0.04 (0.02, 0.06) <0.001 0.05 (0.03, 0.08) 0.02 (0.01, 0.05) 0.073
CD8 T-cells
Age mean, SD (range)
n ¼ 73
43.9, 13.8
(19e71)
n ¼ 99
63.87 8.9
(48e83)
Naïve, mean % 11.52* 15.81* 1.37 (1.01, 1.86)y 0.041 2.08 (3.06, 1.09)z <0.001 1.31 (2.54, 0.07)z 3.41 (5.00, 1.80) 0.042
Memory, mean % 44.13 41.16 2.97 (8.59, 2.67) 0.300 0.25 (0.06, 0.43) 0.010 0.38 (0.15, 0.61) 0.01 (0.30, 0.32) 0.064
IRC, mean % 3.19* 9.10* 2.85 (1.68, 4.85)y <0.001 2.03 (0.25, 3.84)z 0.025 N/A N/A 0.518
n ¼ 19 n ¼ 71
Expansion if
present, mean %
22.03* 17.55* 0.80 (0.55, 1.16)y 0.228 0.09 (0.97, 1.17)z 0.862 N/A N/A 0.869
B-cells
Age mean, SD (range)
n ¼ 44
40.4, 12.9
(31e65)
n ¼ 106
62.1, 8.8
(48e83)
Naïve, mean % 69.36 67.87 1.49 (8.89, 5.91) 0.691 0.45 (0.23, 0.68) <0.001 0.69 (0.37, 1.00) 0.23 (0.08, 0.54) 0.044
Memory, mean % 22.22* 21.99* 0.99 (0.73, 1.34)y 0.946 1.72 (2.62, 0.81)z <0.001 N/A N/A 0.260
Breg, mean % 1.63* 1.93* 1.18 (0.79, 1.77)y 0.412 0.38 (1.59, 0.84)z 0.535 N/A N/A 0.179
n ¼ 21 n ¼ 47
Pre-plasma if present,
mean %
0.80* 0.40* 0.50 (0.25, 1.00)y 0.050 0.94 (3.01, 1.18)z 0.378 N/A N/A 0.990
* Geometric mean.
y Ratio OA: HC.
z Geometric mean percentage change per year.
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older OA patients had higher frequencies (positive trend).CD4þ T-cell phenotypes
Using the same strategy, proportions of naive, memory and IRC
CD4þ T-cells considered simultaneously and having adjusted for
age revealed no apparent difference between groups (F(3,177)¼ 0.30,
P ¼ 0.824), and the association with age was signiﬁcant when ﬁxed
in both groups (F(3,177) ¼ 7.56, P < 0.001).
Looking at each phenotype individually, consistent with the
overall result and current knowledge22 frequencies did not differ
between the HC and OA: naïve CD4þ T-cell frequencies reduced
with age, memory CD4þ T-cell frequencies increased, whilst CD4þ
IRC frequencies did not vary with age (Table II). There was a sig-
niﬁcant interaction with age in the multivariate analysis
(F(3,176) ¼ 3.18, P ¼ 0.026).
Looking at each CD4þ T-cell phenotype individually, known
positive (memory) and negative (naïve) age associations were
observed in HC (Table II and Fig. 3), but neither of these subsets was
associated with age in OA patients.
With respect to CD4þ regulatory T-cells, having adjusted for age,
the OA patients had comparatively fewer Treg than HC (Table II,Fig. 3). When the age effect was ﬁxed in both groups, the frequency
of Treg was higher in older individuals; however the association
with age differed, being positive in HC but absent in OA patients
(Fig. 3).CD8þ T-cell phenotypes
Memory like CD8þ T-cells were not present in all individuals
(n ¼ 90 combing HC and OA) and were therefore analysed sepa-
rately. These cells were more likely to be found in OA patients
(71.7%; 71/99) than in HC (26.0%; 19/73) having adjusted for age
[OR ¼ 14.91 (5.40, 41.18); P < 0.001]. The odds of memory-like cells
being present decreased with age [OR¼ 0.97 (0.94,1.00); P¼ 0.037]
but there was no evidence that this association differed between
HC and OA (P ¼ 0.233). In patients with memory-like cells present,
the proportion of memory-like cells did not differ between HC and
OA (Table II).
When frequencies of naive, memory and IRC CD8þ T-cells were
assessed in simultaneous analysis, evidence of age-adjusted be-
tween-group differences (F(3,167) ¼ 8.30, P < 0.001) and an associ-
ation with age (F(3,167) ¼ 10.02, P < 0.001) were observed.
Looking at individual phenotypes and having adjusted for age,
OA patients tended to havemore naïve and IRC CD8þ T-cells relative
Fig. 3. CD4þ and CD8þ T-cell subset phenotypes in HC and OA. Percentage of CD4þ T-cell (top) and CD8þ T-cell (bottom) subsets in HC (open symbols) and OA (black symbols).
Lines depict signiﬁcant age relationship with subset. The non-broken line represents the relationship when similar in HC and OA, dotted line for relationship in HC only and dash-
dot line for OA only.
Fig. 2. Lineage blood cell composition in HC and OA. Percentage of each cell subset lineage is represented as % total lymphocytes in HC (open symbols) and OA (black symbols). Lines
depict signiﬁcant age relationship as determined by regresion allowing age association to differ between HC and OA in individual subsets (see also Table II). The dotted line
represents the relationship in HC only and dash-dot line in OA only.
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differ between groups. However, a signiﬁcant interaction between
age and group in the multivariate analysis (F(3,166)¼ 3.67, P¼ 0.014)
which persisted in patients aged 48 and over (F(3,128) ¼ 3.59,
P ¼ 0.016) suggested that the extent of between-group differences
was not consistent at all ages.
Naive CD8þ T-cell frequencies reduced with age (Fig. 3) as ex-
pected in HC22 and in OA, but the negative trend with age wassteeper in OA patients (Table II). In HC there was a positive asso-
ciationwith age for memory CD8þ T-cell (as previously reported22),
which was absent in OA patients (Fig. 3). Trends with age did not
differ signiﬁcantly for IRC or memory CD8þ T-cell.
It is worth noting that the proportion of CD8þ T-cell that were
deﬁned as IRC exceeded 1% in almost all of the OA patients (92.0%;
92/100) compared to only 38.7% (29/75) of the HCs. In the majority
of HCs the proportionwas at or around 1%, suggesting that this may
Fig. 4. B-cell subset phenotypes in HC and OA. Percentage of each B-cell subsets in HC (open symbols) and OA (black symbols). Lines depict signiﬁcant age relationship with subset.
The non-broken line represents the relationship when similar in HC and OA, dotted line for relationship in HC only and dash-dot line for OA only.
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the odds of IRC CD8þ T-cells being elevated above 1% in OA and
controlling for age, odds were 14-fold higher (OR ¼ 14.3; 95% CI 5.0
to 40.7; P < 0.001); there was no indication that the odds of
elevated IRC were associated with age (P ¼ 0.331) or that an age
association differed by group (P ¼ 0.848).
B-cell phenotypes
PPC were relatively rare and were investigated separately. The
proportion of individuals with detectable PPC did not differ be-
tween HC (47%; 21/44) and OA (44%; 47/106) and after adjusting for
age (OR ¼ 0.95 (0.33, 2.71); P ¼ 0.924). In people with PPC, there
was a borderline-signiﬁcant difference between the groups, with
OA patients having relatively fewer PPC than HC (Table II). There
was no evidence to suggest that PPC frequency was associated with
age (P ¼ 0.378) or that this (lack of) association differed between
the groups (P ¼ 0.990).
Considering naive, memory and T2/Breg simultaneously, there
was an association with age (F(3,145) ¼ 6.50, P < 0.001) but no evi-
dence of differences between OA and HC (F(3,145) ¼ 0.55, P ¼ 0.646).
Looking at individual phenotypes, naive B-cell frequencies tended
to be higher in older individuals (Fig. 4) whilst memory B-cell
frequencies tended to be lower. T2/Breg frequencies did not vary
with age (Table II, Fig. 4). There was evidence of an interaction
between age and group in the multivariate analysis (F(3,144) ¼ 3.25,
P ¼ 0.024); however, only naïve B-cells showed a difference in the
age association between the HC and OA. There was a relatively
higher naïve-cell frequency with age (positive trend), but this as-
sociation was weaker in OA to the extent that the conﬁdence in-
terval crossed 0.
Clinical correlate to immune cell blood composition
In a subgroup of patients (with reported duration), longer OA
duration was associated with the loss of CD4þ T-cells (n ¼ 62,
rho ¼ 0.297, P ¼ 0.025). In the 46 patients who reported a family
history of OA, there was amore profound loss of total CD4þ/CD8þ T-
cells (P ¼ 0.077). A trend between CD4þ IRC (but not CD8þ) fre-
quency and disease duration was observed (n ¼ 62, rho ¼ þ0.248,
P ¼ 0.058).
For the majority of patients, we had data on the predominant
joints diagnosed with OA (Table I). CD4þ IRC were more frequent in
patients with hip (P¼ 0.002, median 1.3% (range 0.1e8.0) for no hip
vs 2.9% (0.5e7.9) with hip) and foot (P ¼ 0.023, median 1.1% (range
0.1e8.0) vs 2.3% (0.8e5.6) OA). Higher CD4þ IRC frequencies were
also observed in patients with knee OA although with only 12 pa-
tients with no knee OA, signiﬁcance was low (P ¼ 0.300, median
0.8% (range 0.1e2.8) vs 2.0% (0.1e12.7). These data suggest that OAin large joints may be an important determinant of the presence of
CD4þ IRC in the blood.We observed no further association between
demographic and clinical parameters or anatomic OA localisation
for the B-cell subsets/phenotypes.Discussion
Immunosenescence in the elderly encompasses many mecha-
nisms resulting in compromised immune function and subsequent
increased susceptibility to infection, cancer and autoimmune dis-
eases. This novel, though preliminary, analysis of the immune cell
composition of the blood of OA patients showed that several line-
ages and sub-phenotypes of T and B-cells were affected in OA
beyond what appears directly related to ageing and may therefore
reﬂect additional immune dysfunction related to the OA process
itself. We proceeded to an age adjusted analysis that conﬁrmed lack
of age association in health for NK, CD4þ T-cells, B-cells and NKT
cells but a trend for lower frequency for CD8þ T-cells with ageing. In
OA, CD4þ T-cell and B-cell frequency were lower while CD8þ T-cell
frequency was higher compared with HC. With respect to cell
phenotyping, the main differences observed were associated with
the CD8þ T-cells: memory-like cells were 15-fold more likely to be
found in OA independent of age; reduction in naïve cell frequency
with age was more accentuated in OA; while the relationship be-
tween age and memory CD8þ T-cells observed in health was lost in
OA. The odds of increased IRC frequency were also much increased
in OA compared to health. In CD4þ T-cells, the reduction in naïve
and increase in memory and Treg subsets with age previously re-
ported in HC22 were lost in OA. Finally B-cells showed evidence of a
limited disturbance in the age relationship for naïve cells but no
change formemory B-cells and T2/Breg, nor for the presence of PPC.
As a general comment, because the extent of the differences
between groups could vary with age, interpreting the estimated
between-group differences in cell frequency should be done with
caution, as it is difﬁcult to determine whether this is a true obser-
vation without longitudinal data, especially data including people
who develop OA with time. Were these overall differences to be
conﬁrmed, this could be interpreted as a shift in overall blood
composition in OA, but as the proportion of one subset/phenotype
cannot change without affecting at least one other, it is difﬁcult to
identify which speciﬁc lineage/subset drives this difference be-
tween the groups. Despite these limitations, to our knowledge,
these data are the ﬁrst report that the immune cell composition of
the blood of OA patients is affected beyondwhatwould be expected
during ageing.
In health, minor alterations in B lymphocytes were reported in
ageing and the loss of cell-mediated responses was predominantly
associated with alterations in the function of T-cells24. Accordingly,
F. Ponchel et al. / Osteoarthritis and Cartilage 23 (2015) 1870e18781876lineage representations were not strongly associated with age in
health (with the exception of CD8þ T-cells), although clear changes
were observed in particular T and B-cell sub-phenotypes. These
data conﬁrmed previous observations of thymic decline in gener-
ating naïve CD4þ T-cells and CD8þ T-cells with age as well as the
development of memory subset reﬂecting T-cell homeostasis over a
lifetime22. The increase in frequency of regulatory T-cells has been
hypothesized25 but we only veriﬁed it by being able to recruit HC
with a wide age range. B-cells continue to develop throughout life
(releasing naïve cells into the blood stream) while memory cells
developing into plasma cells tend to home to the bone marrow and
therefore leave the blood. Accordingly our data showed increase
and decrease of circulating naïve and memory B-cells respectively.
Previous data showing no differences for CD4þ or CD8þ T-cells
frequencies were reported comparing OA with age-matched HC
over 1 decade of age (mean age 70 range 65e75)26. Our data would
probably have been consistent with these previous results if
restricted to that decade of age. The relative changes of T-cells in OA
(decline in CD4þ and absence of reduction of CD8þ T-cells) were
only visible in our study becausewe included awide range of age in
HC. The decline in CD4þ T-cells may suggest greater loss in T-cell
functionality in OA compare to health. How CD8þ homeostasis is
controlled throughout ageing remains unclear. Clonal expansions of
CD8þ T-cells related to Epstein Barr and/or CMV were shown to
accumulate in ageing27. The presence of such expanded highly
differentiated CD8þ T-cells was shown to be detrimental to
immunity28e30 resulting in the increased morbidity and mortality
of the elderly population. The presence in almost all OA patients of
greatly expanded CD8þ T-cells with an IRC or the memory-like
phenotype may reﬂect an even greater disturbance of CD8þ ho-
meostasis in OA.
The relationship between NKT and age in HC was maintained in
OA. In a few OA patients, however, very high frequencies were
observed (Fig. 2). The role of the NKT population of cells expressing
both T-cell and NK-cell markers is not well understood, but they
functionally work both like NK and T-cells, notably by immediately
producing cytokines when activated (interferon-gamma, tumour
necrosis factor-alpha and IL-2)31,32. NKT-cells are therefore part of
the ﬁrst-line defense mechanism against pathogens including vi-
ruses. One of their functions associated with ageing is to compen-
sate for the deterioration of T-cells and although NKT production of
IFN-gamma also decreased with ageing33 it is better maintained
(notably in centenarian) and is thought to be essential for healthy
ageing. Inﬂammation in metabolic tissues has emerged as a uni-
versal feature of obesity and its co-morbidities, including OA. A link
between diet and NKT frequencies has also been established34 and
mice lacking NKT were more prone to obesity and inﬂammation35.
In OA, patients with high NKT-cell frequencies may therefore sug-
gest different capacities for immediate response to viral infection.
Phenotyping CD4þ T-cells revealed further differences. We
observed a lower frequency of regulatory T-cells, and higher than
expected naïve CD4þ T-cells. This last observationwas intriguing as
it is quite similar to what is observed in RA where such mainte-
nance of high naïve T-cells is predictive of good outcome36. IRC
have been shown to develop as a result of pro-inﬂammatory
cytokine stimulation22. In our study, IRC were more frequent in
patients with large joint OA (hip, knee, foot). It could therefore be
speculated that their presence reﬂects a greater volume of syno-
vitis. Unfortunately we did not have whole body radiographs in
order to fully characterise both the total-body burden and the joint-
level severity of OA in individuals. The reduction of regulatory T-
cells in the blood of OA is also intriguing and this has never been
reported to our knowledge. Such loss of Treg (notably as Treg were
shown to accumulate with ageing) may have important conse-
quences. Autoantibodies are both a feature of ageing and OA and,although a direct role for B-cell auto-reactivity remains a matter of
debate in OA, there is much evidence of accumulated auto-
reactivity, notably towards cartilage epitopes (with autoantibody
to collagens, proteoglycans)37. Loss of regulatory mechanisms may
be contributing to the loss of tolerance resulting in such autoanti-
bodies being generated38. The loss of relationship between total
and naïve B-cell subset and age in OA is not sufﬁcient to suggest
causality although it may suggest that additional disease effect may
be mediated by B-cells, especially considering the highly differen-
tiated state of synovial B-cells39.
The histology and immunohistochemistry analysis of OA syno-
vial biopsies was primarily used to conﬁrm previously reported
data related to the OA synovial membrane cellular composition. T
and B-cell inﬁltrationwas observed and even if aggregates were not
as frequently observed as in RA, their presence in the synovial
tissue suggests immune-related events in OA. Synovitis score were
above normal in all but 13 patients and reached quite high levels.
Taken together with the changes seen in blood cell composition,
our data suggest that immune dysregulation may contribute to OA
in a way that remains to be fully elucidated.
In conclusion, our data suggest that alterations in the blood
immune cell composition can be observed in OA, and such changes
appear different to those associated with ageing alone. Some of the
changes may reﬂect inﬂammation and autoreactivity. The loss of
regulatory mechanisms in OA should therefore be further investi-
gated in relation to auto-antibodies and auto-reactivity develop-
ment. Future research into immune-modulation for the treatment
of OA may be of beneﬁt.
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